Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Salazar

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
Automation in the Thrombosis and Hemostasis LaboratoryEric Salazar, Russell A Higgins
Clinics in Laboratory Medicine|May 15, 2026
Updates on Von Willebrand Disease TestingEric Salazar, Russell A Higgins
BMC Cancer|April 9, 2004
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell linesJamboor K Vishwanatha, Eric Salazar, Velliyur K Gopalakrishnan
Cureus|December 3, 2019
Aortic Valve Replacement in Severe Factor V Deficiency and Inhibitor: Diagnostic and Management ChallengesAlexa Bello, Eric Salazar, Kirk Heyne, et al.
Journal of Thrombosis and Thrombolysis|July 8, 2021
Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case seriesCelia Morton, Annette Lista, Nicholas Jakowenko, et al.
The International Journal of Biochemistry & Cell Biology|March 26, 2014
Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamersNianxi Zhao, Sung-nan Pei, Parag Parekh, et al.
Journal of Cardiac Surgery|February 13, 2020
Evaluation of postoperative clinical outcomes in Jehovah's Witness patients who receive prothrombin complex concentrate during cardiac surgeryJesse E Harris, Sara Varnado, Elizabeth Herrera, et al.
Annals of Clinical and Laboratory Science|July 5, 2018
New Onset Iron Deficiency Anemia in Chronic Therapeutic Plasma Exchange PatientsFrances Compton, Eric Salazar, Kimberly Klein, et al.
Journal of Thrombosis and Thrombolysis|April 17, 2022
Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapyJingshi Chen, Steffany Nguyen, Melanie Ruegger, et al.
Thrombosis Research|September 18, 2020
Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health systemNicholas Jakowenko, Steffany Nguyen, Melanie Ruegger, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2023
Automation in the Thrombosis and Hemostasis LaboratoryEric Salazar, Russell A Higgins
Clinics in Laboratory Medicine|May 15, 2026
Updates on Von Willebrand Disease TestingEric Salazar, Russell A Higgins
BMC Cancer|April 9, 2004
Absence of annexin I expression in B-cell non-Hodgkin's lymphomas and cell linesJamboor K Vishwanatha, Eric Salazar, Velliyur K Gopalakrishnan
Cureus|December 3, 2019
Aortic Valve Replacement in Severe Factor V Deficiency and Inhibitor: Diagnostic and Management ChallengesAlexa Bello, Eric Salazar, Kirk Heyne, et al.
Journal of Thrombosis and Thrombolysis|July 8, 2021
Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case seriesCelia Morton, Annette Lista, Nicholas Jakowenko, et al.
The International Journal of Biochemistry & Cell Biology|March 26, 2014
Blocking interaction of viral gp120 and CD4-expressing T cells by single-stranded DNA aptamersNianxi Zhao, Sung-nan Pei, Parag Parekh, et al.
Journal of Cardiac Surgery|February 13, 2020
Evaluation of postoperative clinical outcomes in Jehovah's Witness patients who receive prothrombin complex concentrate during cardiac surgeryJesse E Harris, Sara Varnado, Elizabeth Herrera, et al.
Annals of Clinical and Laboratory Science|July 5, 2018
New Onset Iron Deficiency Anemia in Chronic Therapeutic Plasma Exchange PatientsFrances Compton, Eric Salazar, Kimberly Klein, et al.
Journal of Thrombosis and Thrombolysis|April 17, 2022
Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapyJingshi Chen, Steffany Nguyen, Melanie Ruegger, et al.
Thrombosis Research|September 18, 2020
Apixaban and rivaroxaban anti-Xa level utilization and associated bleeding events within an academic health systemNicholas Jakowenko, Steffany Nguyen, Melanie Ruegger, et al.
Pageof 6